세계의 심지아(Cimzia) 시장 보고서(2025년) : 역학, 파이프라인 분석, 시장 인사이트 및 예측

Cimzia Global Market Report 2025: Epidemiology, Pipeline Analysis, Market Insights & Forecasts

US $ 4,490 ￦ 6,305,000

PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 6,490 ￦ 9,114,000

PDF (Site License)

PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 8,490 ￦ 11,923,000

PDF (Enterprise License)

PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

한글목차

심지아 시장 규모는 향후 몇 년 동안 급속한 성장을 보일 것으로 예상됩니다. 예측 기간 동안의 성장은 표적 생물학적 제제에 대한 수요 증가, 자가 투여 기기에 대한 환자의 선호도 증가, 바이오시밀러 경쟁의 심화, 정부 의료비 지원 확대, 맞춤형 의약품에 대한 강조 강화 등에 기인할 수 있습니다. 예측 기간의 주요 트렌드로는 환자 중심 의약품 전달 솔루션으로의 전환, 질병 관리를 위한 디지털 건강 도구의 채택, 의약품 개발에 실제 증거의 사용 증가, 원격 의료 및 재택 치료 솔루션의 성장, 임상 시험에 AI의 통합 등이 있습니다.

류마티스 관절염(RA)의 유병률 증가가 심지아 시장의 확장을 촉진할 것으로 예상됩니다. RA는 면역 체계가 신체의 관절 조직을 공격하여 염증, 통증 및 부종을 유발하는 만성 자가 면역 질환입니다. RA 사례의 증가는 인구 고령화, 유전적 소인의 증가, 흡연 및 오염과 같은 환경적 요인, 그리고 이 질환에 대한 인식 및 진단이 높아진 것과 관련이 있을 수 있습니다. 심지아는 염증을 줄이고, 증상을 완화하며, 환자의 복지를 개선하고, 더 나은 질병 관리를 돕는 표적 치료법을 제공함으로써 RA 관리에 중요한 역할을 합니다. 예를 들어, 2022년 5월 영국 기반 자선 단체인 통증 완화 재단(Pain Relief Foundation)은 영국에서 관절염 및 근골격계 질환이 1,700만 명 이상에게 영향을 미쳐 연간 3,000만 일의 근로일 손실을 초래했으며, 만성 통증은 75세 이상 인구의 최대 62%에게 영향을 미친다고 보고했습니다. 또한, 2024년 2월, 미국 질병통제예방센터(CDC)는 18세 이상 성인의 연령 조정 관절염 진단 유병률이 2022년에 18.9%로, 여성(21.5%)이 남성(16.1%)보다 관절염에 걸릴 가능성이 더 높다고 보고했습니다. 따라서 류마티스 관절염의 유병률이 증가하면서 심지아 시장의 성장이 촉진되고 있습니다.

심지아 시장의 주요 동향은 자가 면역 질환 관리, 특히 비방사선 축성 척추 관절염(nr-axSpA) 환자의 미충족 요구를 해결하기 위한 자가 면역 치료 솔루션과 같은 혁신적인 치료법의 개발입니다. 자가면역 치료 솔루션은 표적 면역 요법과 세포 치료를 활용해 면역 균형과 내성을 회복하는 것을 목표로 합니다. 예를 들어, 2024년 7월 벨기에 기반 바이오제약 기업 UCB는 nr-axSpA 환자를 위한 심지아(certolizumab pegol)의 치료 적응증 확대를 발표했습니다. 이 확장은 질병의 방사선학적 증거가 없지만 증상을 겪는 환자에게 혁신적인 치료 옵션을 제공합니다. 심지아는 nr-axSpA에 대한 FDA 승인을 받은 첫 번째 생물학적 제제로, 자가면역 치료 분야에서 독특한 위치를 확립했습니다. 이 승인은 전통적인 치료법에 대한 중요한 대안을 제공하며, 환자의 증상 관리와 삶의 질을 개선합니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 바이오의약품 시장에서의 제품 특성

• 분자 유형
• 투여경로(ROA)
• 작용기전(MOA)
• 안전성과 유효성

제4장 시장 동향과 전략

제5장 시장 - 거시경제 시나리오 금리, 인플레이션, 지정학, 신형 코로나 바이러스 감염, 경기 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제6장 세계의 성장 분석과 전략 분석 프레임워크

• 세계의 심지아 : PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인과 억제요인)
• 최종 이용 산업의 분석
• 세계의 심지아 시장 : 성장률 분석
• 세계의 심지아 시장 실적 : 규모와 성장(2019-2024년)
• 세계의 심지아 시장 예측 : 규모와 성장(2024-2029년, 2034년)
• 세계의 심지아 : 전체 시장 규모(TAM)

제7장 세계 시장의 가격 분석과 예측

제8장 시장 세분화

• 세계의 심지아 시장 : 유형별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
• 생물학적 제제
• 바이오시밀러
• 세계의 심지아 시장 : 환자 인구 통계별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
• 성인
• 소아
• 세계의 심지아 시장 : 유통 채널별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
• 병원 약국
• 약국과 약국
• 온라인 약국
• 세계의 심지아 시장 : 용도별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
• 크론병
• 류마티스 관절
• 강직성 척추염
• 활동성 건선성 관절염
• 축성 척추 관절염
• 심상성 건선

제9장 임상적응증 세계 시장 역학

• 약제의 부작용
• 임상적응증의 발병률과 유병률

제10장 지역별, 국가별 분석

• 세계의 심지아 시장 : 지역별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
• 세계의 심지아 시장 : 국가별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)

제11장 아시아태평양 시장

제12장 중국 시장

제13장 인도 시장

제14장 일본 시장

제15장 호주 시장

제16장 한국 시장

제17장 서유럽 시장

제18장 영국 시장

제19장 독일 시장

제20장 프랑스 시장

제21장 동유럽 시장

제22장 북미 시장

제23장 미국 시장

제24장 캐나다 시장

제25장 남미 시장

제26장 중동 시장

제27장 아프리카 시장

제28장 경쟁 구도와 기업 프로파일

• 심지아 시장 : 경쟁 구도
• 심지아 시장 : 기업 프로파일
  • UCB SA

제29장 세계 시장 : 파이프라인 분석

제30장 세계 시장 경쟁 벤치마킹과 대시보드

제31장 주요 인수합병(M&A)

제32장 최근 시장 동향

제33장 시장의 잠재력이 높은 국가, 전략

• 심지아 시장(2029년) : 새로운 기회를 제공하는 국가
• 심지아 시장(2029년) : 새로운 기회를 제공하는 부문
• 심지아 시장(2029년) : 성장 전략
  • 시장 동향에 의한 전략
  • 경쟁 전략

제34장 부록

HBR

영문 목차

영문목차

Cimzia (certolizumab pegol) is a PEGylated monoclonal antibody that targets tumor necrosis factor (TNF), used to reduce inflammation and prevent immune system-related damage in certain autoimmune diseases. It is used in treating moderate to severe rheumatoid arthritis, Crohn's disease, psoriatic arthritis, ankylosing spondylitis, and hidradenitis suppurativa.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The primary types of cimzia are biologics and biosimilars, designed to address the needs of both adult and pediatric patients. Cimzia is distributed through various channels, including hospital pharmacies, drug stores, retail pharmacies, and online pharmacies. Its applications extend to treating conditions such as Crohn's disease, rheumatoid arthritis, ankylosing spondylitis, active psoriatic arthritis, axial spondyloarthritis, and plaque psoriasis.

The cimzia market research report is one of a series of new reports from The Business Research Company that provides cimzia market statistics, including cimzia industry global market size, regional shares, competitors with a cimzia market share, detailed cimzia market segments, market trends and opportunities, and any further data you may need to thrive in the cimzia industry. This cimzia market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The cimzia market size is expected to see rapid growth in the next few years. It will grow to $6,776.6 million in 2029 at a compound annual growth rate (CAGR) of 17%. The growth in the forecast period can be attributed to rising demand for targeted biologics, increasing patient preference for self-administration devices, growth in biosimilar competition, increasing government healthcare funding, and growing emphasis on personalized medicine. Major trends in the forecast period include shift towards patient-centric drug delivery solutions, adoption of digital health tools for disease management, increasing use of real-world evidence in drug development, growth of telemedicine and home care solutions, and integration of AI in clinical trials.

The growing prevalence of rheumatoid arthritis (RA) is expected to drive the expansion of the cimzia market. RA is a chronic autoimmune disorder where the immune system attacks the body's joint tissues, causing inflammation, pain, and swelling. The rise in RA cases can be linked to an aging population, increasing genetic predisposition, environmental factors such as smoking and pollution, and greater awareness and diagnosis of the condition. Cimzia plays a crucial role in managing RA by providing targeted therapy to reduce inflammation, relieve symptoms, improve patient well-being, and aid in better disease management. For example, in May 2022, the Pain Relief Foundation, a UK-based charity, reported that arthritis and musculoskeletal conditions affect over 17 million people in the UK, leading to 30 million lost working days annually, while chronic pain affects up to 62% of those over 75. Additionally, in February 2024, the Centers for Disease Control and Prevention (CDC) reported that the age-adjusted prevalence of diagnosed arthritis in adults aged 18 and older was 18.9% in 2022, with women (21.5%) more likely to have arthritis than men (16.1%). Therefore, the increasing prevalence of rheumatoid arthritis is driving the growth of the cimzia market.

A key trend in the cimzia market is the development of innovative treatments, such as autoimmune therapy solutions, to address unmet needs in autoimmune disease management, particularly for patients with non-radiographic axial spondyloarthritis (nr-axSpA). Autoimmune therapy solutions aim to restore immune balance and tolerance, often using targeted immunotherapies and cellular therapies. For example, in July 2024, UCB, a Belgium-based biopharmaceutical company, announced the expansion of Cimzia (certolizumab pegol) as a treatment for patients with nr-axSpA. This expansion provides an innovative option for patients who have not yet shown radiographic evidence of the disease but still experience symptoms. Cimzia is the first biologic to receive FDA approval for nr-axSpA, establishing its unique position in autoimmune treatment. This approval offers an important alternative to traditional therapies, improving symptom management and quality of life for patients.

In February 2022, Biogen Inc., a US-based biotechnology company, entered into a licensing agreement with Xbrane Biopharma, a Sweden-based biopharmaceutical company, to develop, manufacture, and commercialize Xcimzane, a biosimilar to Cimzia. This partnership aims to provide more affordable treatment options for patients with rheumatoid arthritis and other conditions, promoting better access to care and contributing to healthcare savings through the availability of a cost-effective alternative to the original drug.

Key player operating in the cimzia market is UCB SA

North America was the largest region in the cimzia market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in cimzia report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the cimzia market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The cimzia market consists of sales of injectable formulations, pre-filled syringes, auto-injectors, and IV infusions. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Cimzia Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on cimzia market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 10 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 3-4 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for cimzia ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The cimzia market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type: Biologics; Biosimilars
• 2) By Patient Demographics: Adults; Pediatrics
• 3) By Distribution Channels: Hospital Pharmacies; Drug Stores And Retail Pharmacies; Online Pharmacies
• 4) By Application: Crohn's Disease; Rheumatoid Arthritis; Ankylosing Spondylitis; Active Psoriatic Arthritis; Axial Spondyloarthritis; Plaque Psoriasis
• Companies Mentioned: UCB SA
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Cimzia Market Characteristics

3. Cimzia Market Biologic Drug Characteristics

• 3.1. Molecule Type
• 3.2. Route Of Administration (ROA)
• 3.3. Mechanism Of Action (MOA)
• 3.4. Safety And Efficacy

4. Cimzia Market Trends And Strategies

5. Cimzia Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

6. Global Cimzia Growth Analysis And Strategic Analysis Framework

• 6.1. Global Cimzia PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 6.2. Analysis Of End Use Industries
• 6.3. Global Cimzia Market Growth Rate Analysis
• 6.4. Global Cimzia Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 6.5. Global Cimzia Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 6.6. Global Cimzia Total Addressable Market (TAM)

7. Global Cimzia Market Pricing Analysis & Forecasts

8. Cimzia Market Segmentation

• 8.1. Global Cimzia Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Biologics
• Biosimilars
• 8.2. Global Cimzia Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Adults
• Pediatrics
• 8.3. Global Cimzia Market, Segmentation By Distribution Channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospital Pharmacies
• Drug Stores And Retail Pharmacies
• Online Pharmacies
• 8.4. Global Cimzia Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Crohn's Disease
• Rheumatoid Arthritis
• Ankylosing Spondylitis
• Active Psoriatic Arthritis
• Axial Spondyloarthritis
• Plaque Psoriasis

9. Global Cimzia Market Epidemiology Of Clinical Indications

• 9.1. Drug Side Effects
• 9.2. Incidence And Prevalence of Clinical Indications

10. Cimzia Market Regional And Country Analysis

• 10.1. Global Cimzia Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. Global Cimzia Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Asia-Pacific Cimzia Market

• 11.1. Asia-Pacific Cimzia Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 11.2. Asia-Pacific Cimzia Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Asia-Pacific Cimzia Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Asia-Pacific Cimzia Market, Segmentation By Distribution Channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. China Cimzia Market

• 12.1. China Cimzia Market Overview
• 12.2. China Cimzia Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 12.3. China Cimzia Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 12.4. China Cimzia Market, Segmentation By Distribution Channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

13. India Cimzia Market

• 13.1. India Cimzia Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. India Cimzia Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. India Cimzia Market, Segmentation By Distribution Channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. Japan Cimzia Market

• 14.1. Japan Cimzia Market Overview
• 14.2. Japan Cimzia Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. Japan Cimzia Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. Japan Cimzia Market, Segmentation By Distribution Channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Australia Cimzia Market

• 15.1. Australia Cimzia Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.2. Australia Cimzia Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Australia Cimzia Market, Segmentation By Distribution Channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. South Korea Cimzia Market

• 16.1. South Korea Cimzia Market Overview
• 16.2. South Korea Cimzia Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. South Korea Cimzia Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.4. South Korea Cimzia Market, Segmentation By Distribution Channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Western Europe Cimzia Market

• 17.1. Western Europe Cimzia Market Overview
• 17.2. Western Europe Cimzia Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Western Europe Cimzia Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.4. Western Europe Cimzia Market, Segmentation By Distribution Channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. UK Cimzia Market

• 18.1. UK Cimzia Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. UK Cimzia Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. UK Cimzia Market, Segmentation By Distribution Channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Germany Cimzia Market

• 19.1. Germany Cimzia Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Germany Cimzia Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Germany Cimzia Market, Segmentation By Distribution Channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. France Cimzia Market

• 20.1. France Cimzia Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. France Cimzia Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. France Cimzia Market, Segmentation By Distribution Channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Cimzia Market

• 21.1. Eastern Europe Cimzia Market Overview
• 21.2. Eastern Europe Cimzia Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Cimzia Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Cimzia Market, Segmentation By Distribution Channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. North America Cimzia Market

• 22.1. North America Cimzia Market Overview
• 22.2. North America Cimzia Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. North America Cimzia Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.4. North America Cimzia Market, Segmentation By Distribution Channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. USA Cimzia Market

• 23.1. USA Cimzia Market Overview
• 23.2. USA Cimzia Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. USA Cimzia Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. USA Cimzia Market, Segmentation By Distribution Channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. Canada Cimzia Market

• 24.1. Canada Cimzia Market Overview
• 24.2. Canada Cimzia Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. Canada Cimzia Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. Canada Cimzia Market, Segmentation By Distribution Channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. South America Cimzia Market

• 25.1. South America Cimzia Market Overview
• 25.2. South America Cimzia Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. South America Cimzia Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. South America Cimzia Market, Segmentation By Distribution Channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. Middle East Cimzia Market

• 26.1. Middle East Cimzia Market Overview
• 26.2. Middle East Cimzia Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. Middle East Cimzia Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. Middle East Cimzia Market, Segmentation By Distribution Channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Africa Cimzia Market

• 27.1. Africa Cimzia Market Overview
• 27.2. Africa Cimzia Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Africa Cimzia Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.4. Africa Cimzia Market, Segmentation By Distribution Channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Cimzia Market Competitive Landscape And Company Profiles

• 28.1. Cimzia Market Competitive Landscape
• 28.2. Cimzia Market Company Profiles
  • 28.2.1. UCB SA Overview, Products and Services, Strategy and Financial Analysis

29. Global Cimzia Market Pipeline Analysis

• 29.1. High Level Clinic Trail Information

30. Global Cimzia Market Competitive Benchmarking And Dashboard

31. Key Mergers And Acquisitions In The Cimzia Market

32. Recent Developments In The Cimzia Market

33. Cimzia Market High Potential Countries, Segments and Strategies

• 33.1 Cimzia Market In 2029 - Countries Offering Most New Opportunities
• 33.2 Cimzia Market In 2029 - Segments Offering Most New Opportunities
• 33.3 Cimzia Market In 2029 - Growth Strategies
  • 33.3.1 Market Trend Based Strategies
  • 33.3.2 Competitor Strategies

34. Appendix

• 34.1. Abbreviations
• 34.2. Currencies
• 34.3. Historic And Forecast Inflation Rates
• 34.4. Research Inquiries
• 34.5. The Business Research Company
• 34.6. Copyright And Disclaimer

관련자료